Cancer begins as a nearby sickness, yet it can metastasize to the lymph hubs and far off organs. At essential finding, prognostic markers are utilized to survey whether the move to systemic illness is probably going to have happened. The overall model of metastasis mirrors this view - it recommends that metastatic limit is a late, obtained occasion in tumourigenesis. Others have proposed the possibility that breast tumour is inherently a systemic sickness. New atomic advancements, for example, DNA microarrays, bolster metastatic limit may be an innate component of breast tumours. This information has critical ramifications for visualization predicition and our comprehension of metastasis
Hanahan and Weinberg introduced the “hallmarks of cancer” and typified essential biological abilitie...
Within the past few years, the measurement of serum and tissue markers, especially the latter, has a...
In recent years, the study of genomic alterations and protein expression involved in the pathways of...
Despite improvements in breast cancer therapies, cancer cells frequently spread to distant organs ye...
Despite important progress in adjuvant and neoadjuvant therapies, metastatic disease often develops ...
Breast cancer is a heterogeneous disease and its consequent complexity is a major challenge for phys...
Tumor cell dissemination in bone marrow or other organs is thought to represent an important step in...
In this issue of the Journal, O’Connell et al. (1) describe the identification of a region on the lo...
Invasive breast cancer tends to metastasize to lymph nodes and systemic sites. The management of met...
Background: Histologically similar tumors may have different prognoses and responses to treatment. T...
Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the prim...
Background: Liquid biopsy provides real-time data about prognosis and actionable mutations in metast...
Breast cancer is the most common malignancy in women worldwide. Metastasis is the leading cause of h...
Breast cancer, the most prevalent type of cancer in women, is usually detected with a lump in breast...
© 2019 ABMSFBIH. Distant organ tumor dissemination is a major cause of breast cancer-related deaths....
Hanahan and Weinberg introduced the “hallmarks of cancer” and typified essential biological abilitie...
Within the past few years, the measurement of serum and tissue markers, especially the latter, has a...
In recent years, the study of genomic alterations and protein expression involved in the pathways of...
Despite improvements in breast cancer therapies, cancer cells frequently spread to distant organs ye...
Despite important progress in adjuvant and neoadjuvant therapies, metastatic disease often develops ...
Breast cancer is a heterogeneous disease and its consequent complexity is a major challenge for phys...
Tumor cell dissemination in bone marrow or other organs is thought to represent an important step in...
In this issue of the Journal, O’Connell et al. (1) describe the identification of a region on the lo...
Invasive breast cancer tends to metastasize to lymph nodes and systemic sites. The management of met...
Background: Histologically similar tumors may have different prognoses and responses to treatment. T...
Metastases have been widely thought to arise from rare, selected, mutation-bearing cells in the prim...
Background: Liquid biopsy provides real-time data about prognosis and actionable mutations in metast...
Breast cancer is the most common malignancy in women worldwide. Metastasis is the leading cause of h...
Breast cancer, the most prevalent type of cancer in women, is usually detected with a lump in breast...
© 2019 ABMSFBIH. Distant organ tumor dissemination is a major cause of breast cancer-related deaths....
Hanahan and Weinberg introduced the “hallmarks of cancer” and typified essential biological abilitie...
Within the past few years, the measurement of serum and tissue markers, especially the latter, has a...
In recent years, the study of genomic alterations and protein expression involved in the pathways of...